Sydney - Friday - August 1: (RWE Australian Business News) -
HeartWare (ASX: HTW) says the Institutional Review Board of Washington
Hospital Center has approved centre's participation in the clinical
trial of the HeartWare Left Ventricular Assist System.
It is the first US centre to approve the study.